Novel Direct Alpha Spectroscopy Technique for $^{225}$Ac Radiopharmaceutical detection in Cancer Cells

Fuente: arXiv
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Farasat, Mahsa, Saeedi, Behrad, Wharton, Luke, Shapiro, Sidney, Vinnick, Chris, Daignault, Madison, Kostashuk, Meghan, Pranjatno, Nicholas, Weiman, Myla, Andreoiu, Corina, Yang, Hua, Kunz, Peter
Format: Preprint
Veröffentlicht: 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866915289438879744
author Farasat, Mahsa
Saeedi, Behrad
Wharton, Luke
Shapiro, Sidney
Vinnick, Chris
Daignault, Madison
Kostashuk, Meghan
Pranjatno, Nicholas
Weiman, Myla
Andreoiu, Corina
Yang, Hua
Kunz, Peter
author_facet Farasat, Mahsa
Saeedi, Behrad
Wharton, Luke
Shapiro, Sidney
Vinnick, Chris
Daignault, Madison
Kostashuk, Meghan
Pranjatno, Nicholas
Weiman, Myla
Andreoiu, Corina
Yang, Hua
Kunz, Peter
contents Targeted alpha-particle therapy (TAT) employs alpha-emitting radionuclides conjugated to tumor-targeting molecules to deliver localized radiation to cancer cells, showing great promise in treating metastatic cancers. Among these radionuclides, Actinium-225 ($^{225}$Ac, t$_{1/2}$ = 9.9 days) has emerged as a clinically promising candidate. Its decay chain generates four successive alpha emissions, resulting in highly localized and effective cytotoxic damage to cancer cells when delivered to tumor sites. However, the assumption of complete retention of $^{225}$Ac and its radioactive daughters at these target sites is often inaccurate. The nuclear recoil effect can lead to off-target distribution and unintended toxicity. Our results revealed distinct spectral differences between radiolabeled cells and reference samples, demonstrating [$^{225}$Ac]Ac-crown-TATE uptake by AR42J cells. Detection of $^{213}$Po, one of the $^{225}$Ac decay daughters, highlighted partial retention and release of decay products from cells, providing information on intracellular retention and daughter redistribution. Geant4 simulations confirmed the alignment of experimental data with theoretical models, validating the method's accuracy. This study establishes a direct alpha spectroscopy approach for investigating $^{225}$Ac and its daughters' behavior in cells and offers a powerful tool for microdosimetry estimation.
format Preprint
id arxiv_https___arxiv_org_abs_2501_10608
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Novel Direct Alpha Spectroscopy Technique for $^{225}$Ac Radiopharmaceutical detection in Cancer Cells
Farasat, Mahsa
Saeedi, Behrad
Wharton, Luke
Shapiro, Sidney
Vinnick, Chris
Daignault, Madison
Kostashuk, Meghan
Pranjatno, Nicholas
Weiman, Myla
Andreoiu, Corina
Yang, Hua
Kunz, Peter
Medical Physics
Nuclear Experiment
Accelerator Physics
Targeted alpha-particle therapy (TAT) employs alpha-emitting radionuclides conjugated to tumor-targeting molecules to deliver localized radiation to cancer cells, showing great promise in treating metastatic cancers. Among these radionuclides, Actinium-225 ($^{225}$Ac, t$_{1/2}$ = 9.9 days) has emerged as a clinically promising candidate. Its decay chain generates four successive alpha emissions, resulting in highly localized and effective cytotoxic damage to cancer cells when delivered to tumor sites. However, the assumption of complete retention of $^{225}$Ac and its radioactive daughters at these target sites is often inaccurate. The nuclear recoil effect can lead to off-target distribution and unintended toxicity. Our results revealed distinct spectral differences between radiolabeled cells and reference samples, demonstrating [$^{225}$Ac]Ac-crown-TATE uptake by AR42J cells. Detection of $^{213}$Po, one of the $^{225}$Ac decay daughters, highlighted partial retention and release of decay products from cells, providing information on intracellular retention and daughter redistribution. Geant4 simulations confirmed the alignment of experimental data with theoretical models, validating the method's accuracy. This study establishes a direct alpha spectroscopy approach for investigating $^{225}$Ac and its daughters' behavior in cells and offers a powerful tool for microdosimetry estimation.
title Novel Direct Alpha Spectroscopy Technique for $^{225}$Ac Radiopharmaceutical detection in Cancer Cells
topic Medical Physics
Nuclear Experiment
Accelerator Physics
url https://arxiv.org/abs/2501.10608